3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
35
Neoplasm Metastasis
7
Ovarian Neoplasms
6
Sarcoma
4
Neoplasms
4
Lymphoma, Non-Hodgkin
4
Pancreatic Neoplasms
3
Multiple Myeloma
3
Lymphoma
3
Glioma
3
Endometrial Neoplasms
3
Carcinoma, Renal Cell
3
Wilms Tumor
2
Uterine Cervical Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Neoplasms by Site
2
Medulloblastoma
2
Lymphoma, Mantle-Cell
2
Lung Neoplasms
2
Liposarcoma
2
Leukemia, Myeloid, Acute
2
Histiocytosis, Langerhans-Cell
2
Interventions
Specimen Handling
5
Biopsy
5
Whole-Body Irradiation
3
Mycophenolic Acid
3
Cyclosporine
3
Cyclophosphamide
3
Azacitidine
3
venetoclax
2
ruxolitinib
2
fludarabine phosphate
2
decitabine and cedazuridine drug combination
2
Sirolimus
2
Melphalan
2
Injections
2
Granulocyte Colony-Stimulating Factor
2
Decitabine
2
Busulfan
2
veliparib
1
tocilizumab
1
tagraxofusp
1
posaconazole
1
peginterferon alfa-2b
1
iadademstat
1
gilteritinib
1
fludarabine
1
fedratinib
1
axatilimab
1
Tranexamic Acid
1
Topotecan
1
Tacrolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic-Myeloproliferative Diseases
×
palbociclib
×
90 days
×
Clear all
No trials found.